Therapeutic Asset Ratings
20,292 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
DEXAMETHASONE
Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma
National Cancer Institute (NCI)
P2
BBB
(74)
FILGRASTIM
Fanconi Anemia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
BBB
(74)
Firsocostat
Nonalcoholic Steatohepatitis
Gilead Sciences
P2
BBB
(74)
Fludarabine
Relapsed T-Cell Lymphoma
GC Cell Corporation
P2
BBB
(74)
Irinotecan
Adult Giant Cell Glioblastoma
Case Comprehensive Cancer Center
P2
BBB
(74)
Irinotecan
Brain and Central Nervous System Tumors
EpicentRx, Inc.
P2
BBB
(74)
Irinotecan
Stage IV Rectal Cancer
Fudan University
P2
BBB
(74)
Nilotinib
Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)
The University of Hong Kong
P2
BBB
(74)
(+)-VINCRISTINE
Adult Giant Cell Glioblastoma
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
P2
BBB
(74)
(+)-VINCRISTINE
Brain and Central Nervous System Tumors
Medical University of Vienna
P2
BBB
(74)
VINCRISTINE SULFATE
AIDS-related Peripheral/Systemic Lymphoma
National Cancer Institute (NCI)
P2
BBB
(74)
asc30
Chronic Weight Management
Ascletis Pharma (China) Co., Limited
P2
BBB
(73)
Azacitidine
Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11
The First Affiliated Hospital of Soochow University
P2
BBB
(73)
Cediranib
Adult Anaplastic Astrocytoma
National Cancer Institute (NCI)
P2
BBB
(73)
Cediranib
Adult Anaplastic Oligodendroglioma
National Cancer Institute (NCI)
P2
BBB
(73)
Cediranib
Adult Giant Cell Glioblastoma
Lawrence Recht
P2
BBB
(73)
Cediranib
Adult Glioblastoma
Lawrence Recht
P2
BBB
(73)
Cediranib
Adult Mixed Glioma
National Cancer Institute (NCI)
P2
BBB
(73)
Cediranib
Brain and Central Nervous System Tumors
National Cancer Institute (NCI)
P2
BBB
(73)
Cediranib
Recurrent Childhood Rhabdomyosarcoma
National Cancer Institute (NCI)
P2
BBB
(73)
Cediranib
Recurrent Colon Cancer
National Cancer Institute (NCI)
P2
BBB
(73)
Cediranib
Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
National Cancer Institute (NCI)
P2
BBB
(73)
Cediranib
Recurrent Neuroblastoma
National Cancer Institute (NCI)
P2
BBB
(73)
Cediranib
Recurrent Non-small Cell Lung Cancer
Wake Forest University Health Sciences
P2
BBB
(73)
Cediranib
Recurrent Osteosarcoma
National Cancer Institute (NCI)
P2
BBB
(73)
Showing 26 to 50 of 20,292 assets
Previous
Page 2 of 812
Next